• Canagliflozin Enhances Mitochondrial Function in Diabetic Ki

  2026-05-01

  This study elucidates that canagliflozin, a selective SGLT2 inhibitor, promotes structural and functional mitochondrial improvements in proximal tubular cells of hypertensive–diabetic mice. These findings reveal mechanisms beyond glycemic control, supporting the compound’s relevance in renal protection and advancing the understanding of mitochondrial modulation in diabetic kidney disease.

• GLP-1 (9-36) Amide: Precision Tool for GLP-1R Antagonist Stu

  2026-04-30

  GLP-1 (9-36) amide from APExBIO empowers metabolic and diabetes researchers with unmatched specificity for dissecting GLP-1 receptor signaling. Grounded in state-of-the-art FRET cAMP assay findings, this guide details optimized workflows, proven troubleshooting, and actionable protocol parameters for reproducible GPCR pathway interrogation.

• Mitomycin C: From DNA Damage to Translational Impact

  2026-04-30

  This article offers translational researchers a comprehensive, evidence-driven perspective on Mitomycin C as a gold-standard antitumor antibiotic and apoptosis signaling tool. Integrating mechanistic insight, protocol best practices, and competitive context, we showcase how APExBIO’s Mitomycin C (SKU A4452) enables precise, next-generation workflows in cancer research. The discussion bridges key findings from prokaryotic and eukaryotic systems, references recent literature, and provides actionable guidance for maximizing translational impact.

• Bazedoxifene as a Potent Antimalarial via Hemozoin Inhibitio

  2026-04-29

  Sudhakar et al. report that Bazedoxifene, a third-generation selective estrogen receptor modulator primarily used in postmenopausal osteoporosis research, exhibits significant antimalarial activity by inhibiting hemozoin formation in Plasmodium falciparum and P. berghei models. Their findings illuminate a promising repurposing strategy, leveraging established safety profiles for novel antiparasitic applications.

• A Tunable Human Intestinal Organoid: Self-Renewal and Differ

  2026-04-29

  This study introduces a refined human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using a combination of small molecule pathway modulators. The innovation enables scalable, high-diversity organoid cultures without artificial niche gradients, offering new opportunities for disease modeling and high-throughput research.

• Pravastatin Sodium: Selective HMG-CoA Reductase Inhibitor In

  2026-04-28

  Pravastatin sodium is a highly selective HMG-CoA reductase inhibitor that precisely suppresses cholesterol biosynthesis and reduces LDL cholesterol. This article provides atomic, evidence-based claims with protocol parameters for research and clinical translation.

• CCCP: Precision Mitochondrial Proton Gradient Disruption in

  2026-04-28

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is a gold-standard tool for controlled disruption of mitochondrial proton gradients, enabling dynamic modeling of neurodegenerative disease and live-cell imaging. Its robust, reproducible performance underpins both protocol optimization and advanced biomarker discovery, as highlighted by cutting-edge AI-driven studies.

• X-Gal in Blue-White Screening: Protocols, Pitfalls & Innovat

  2026-04-27

  X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) stands at the core of precise blue-white colony screening and β-galactosidase assays, offering robust visual readouts fundamental to molecular cloning. This article explores advanced workflow optimization, troubleshooting strategies, and research-driven enhancements—anchored in the latest olfactory biology findings—to help molecular biologists achieve clear, reliable results.

• JZL184: Advancing Endocannabinoid Modulation in TBI Models

  2026-04-27

  Explore how the selective monoacylglycerol lipase inhibitor JZL184 enables precise endocannabinoid signaling modulation in traumatic brain injury research. This article delivers an in-depth, evidence-driven analysis distinct from existing resources.

• ECM1 Epitope LA Primes CD8+ T and NK Cells via DC Cross-Acti

  2026-04-26

  Yu et al. (2021) identify an HLA-A2.1-restricted ECM1-derived epitope (LA) that robustly activates both CD8+ T cells and NK cells through dendritic cell (DC) cross-activation. Their work establishes a mechanistic foundation and preclinical validation for a dual-activation tumour vaccine strategy, with implications for future immunotherapy design.

• Exo1 (SKU B6876): Precision in Exocytic Pathway Inhibition

  2026-04-25

  This article delivers scenario-driven, evidence-based guidance for implementing Exo1 (SKU B6876; methyl 2-(4-fluorobenzamido)benzoate) in membrane trafficking and exocytosis assays. By addressing real laboratory challenges with literature-backed solutions, we highlight how Exo1 enhances assay reproducibility, ARF1 pathway specificity, and workflow reliability for biomedical researchers.

• Reliable Native PAGE: Basic Protein Gel Kit (PI ≤ 7.0) Scena

  2026-04-24

  This article provides scenario-driven, evidence-based guidance for researchers using the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) (SKU K4142). Real laboratory challenges are addressed with quantitative context and actionable workflow solutions, demonstrating how this kit preserves protein activity and improves reproducibility in native protein gel electrophoresis applications.

• Peptidisc-Assisted Clustering: Engineering Multimeric Nanobo

  2026-04-24

  This article reviews a new approach for engineering multimeric and multispecific nanobody proteins using peptidisc-assisted hydrophobic clustering. The study demonstrates that fusing nanobodies to transmembrane segments enables stable, water-soluble oligomeric assemblies, expanding the protein engineering toolkit for enhanced affinity and multifunctionality.

• Polyethylenimine Linear (PEI, MW 40,000): Evidence & Protoco

  2026-04-23

  Polyethylenimine Linear (PEI), MW 40,000 is a leading DNA transfection reagent for in vitro studies, enabling high-efficiency transient gene expression in mammalian cells. Its cationic linear structure condenses DNA and supports scalable, serum-compatible workflows. APExBIO supplies a validated formulation (K1029) with robust literature and protocol support for reproducible results.

• Sitagliptin Phosphate Monohydrate: Reliable DPP-4 Inhibitor

  2026-04-23

  This article addresses practical laboratory challenges in cell viability and metabolic research, demonstrating how Sitagliptin phosphate monohydrate (SKU A4036) from APExBIO delivers reproducible, data-backed results. With scenario-driven Q&A and protocol-focused guidance, researchers gain actionable insights into assay optimization and vendor selection for DPP-4 inhibitor studies.

15965 records 1/1065 page Next 12345 下5页 Last page